Stimulant Medications May Benefit ADHD With Stimulant Use Disorder, finds study

Medical Dialogues

A meta-analysis found that high-dose methylphenidate and mixed amphetamine salts (MAS) significantly improved ADHD symptoms and reduced stimulant use compared to placebo. MAS, particularly at 80 mg, showed the highest efficacy in reducing stimulant use, while high-dose methylphenidate (180 mg) was most effective for symptom reduction. The study suggests that stimulant medications may be beneficial for individuals with co-occurring ADHD and stimulant use disorder, with a safety profile comparable to placebo.

Read at Medical Dialogues

All articles from 10 November 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.

Get this news by email

Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the subscribe page.

More to read